Skip to search formSkip to main contentSkip to account menu

gastrointestinal perforation

Known as: GASTROINTESTINAL PERFORATION (NOS), GI PERFORATION, Digestive System Perforation 
A rupture in the wall of any structure of the digestive system caused by traumatic or pathologic processes.
National Institutes of Health

Related topics

Related topics

3 relations
Esophageal PerforationGastrointestinal DiseasesIntestinal Perforation

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study.
Highly Cited
2010
Highly Cited
2010
“Sparing the surgeon”: clinical experience with over-the-scope clips for gastrointestinal perforation
With increasingly advanced therapeutic endoscopic procedures and more complex gastrointestinal surgery, endoscopists are more… 
Review
2007
Review
2007
Experience with bevacizumab in the management of epithelial ovarian cancer.
Müllerian duct adenocarcinomas, in particular epithelial ovarian cancers, continue to represent a major source of female cancer… 
Highly Cited
2006
Highly Cited
2006
Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: report of three cases.
Highly Cited
2006
Highly Cited
2006
Bevacizumab combination therapy in recurrent, platinum‐refractory, epithelial ovarian carcinoma
The study was undertaken to determine the safety and efficacy of the monoclonal, antivascular endothelial growth factor antibody… 
Highly Cited
2006
Highly Cited
2006
Foodborne bacterial infection and hospitalization: a registry-based study.
Review
2006
Review
2006
Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer
Bevacizumab is an angiogenesis inhibitor and a new therapy for the treatment of colorectal cancer. It is a humanized monoclonal… 
Highly Cited
2005
Highly Cited
2005
Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants.
Highly Cited
1997
Highly Cited
1997
Evidence of aspirin use in both upper and lower gastrointestinal perforation.
BACKGROUND & AIMS Current studies lack appropriate data on aspirin and other risk factors for gastrointestinal perforation. The… 
Review
1985
Review
1985
Increased risk of gastrointestinal perforations in neonates mechanically ventilated with either face mask or nasal prongs.
Twenty cases of gastrointestinal perforations not associated with necrotizing enterocolitis or a bowel obstruction (GPNN) were… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)